Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2026-02-20 @ 6:38 PM
Study NCT ID:
NCT00869895
Status:
COMPLETED
Last Update Posted:
2016-01-29
First Post:
2009-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors
Sponsor:
Eisai Inc.
Organization:
Study Overview
Official Title:
A Phase I Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors
Status:
COMPLETED
Status Verified Date:
2012-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the maximum tolerated dose (MTD) of E7050 given orally in patients with advanced solid tumors.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: